• The brain cancer glioblastoma affects about 3 in every 100,000 people around the world each year. 
  • Glioblastoma is difficult to treat, and people with this condition have an average survival length of approximately 1 year.
  • Researchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the body’s immune system to attack and potentially treat glioblastoma. 



I have no doubt this gene modification injection will be as safe and effective as the first one!